A look at this week's top stories.
A study published in the journal Sleep and Breathing found sleep quality influenced newborn weight in a gender-specific and trimester-specific way.
A review of the risks, benefits, and indications for appropriate referral of fetal echocardiography
An umbrella review of meta-analysis studies on hormonal contraceptives published in JAMA Network Open finds no high-quality evidence that they cause major adverse health outcomes such as stroke or cancer.
Understanding the effects is imperative for patient satisfaction.
In an effort to identify abnormal bleeding patterns and their prevalence and confirm existing and expected associations, a study was conducted as part of Apple’s larger Women’s Health Study.
Fertility myths and declining sexual satisfaction may contribute to shortfalls in contraceptive use after cancer treatment, a new study concludes.
Women in the late reproductive stage may experience menopause-related symptoms that could impact their quality of life, according to new research.
Labels of Plan B One-Step had previously stated—without scientific evidence—that the pill might block fertilized eggs from implanting in the womb.
The Food and Drug Administration (FDA) has approved another Tdap vaccine option for use during pregnancy to prevent pertussis, otherwise known as whooping cough.
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
Improved maternal cardiac arrest management reported from Obstetric Life Support training
November 19th 2024A study found that Obstetric Life Support education significantly improves health care providers' readiness and outcomes in maternal cardiac arrest management, advocating for broader implementation.
Read More